Clinical trial
ATERO: A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler…
NCT00355108 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00355108 |
|---|---|
| Title | ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome |
| Official title | ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome. Beneficial or Iatrogenic Effects. |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Telangiectasia, Hereditary Hemorrhagic, Osler-Rendu Disease |
| Intervention type | Drug |
| Interventions | tranexamic acid |
| Enrollment | 170 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jul 21, 2006 |
| Last update posted | May 28, 2019 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: